CbsBioscience is specialized in precision medicine driven by big data & artificial intelligence technology.
Since 2003, we strive to develop innovative technologies in precision medicine to improve cancer patients’ quality of life.
We conduct international collaborative researches with global prestigious institutes and researchers to tackle the unmet need in cancer treatment, such as liver cancer, breast cancer, gastric cancer, lung cancer, colorectal cancer, etc.
Innovative technology for precision medicine includes prognosis, predictive biomarkers as well as biomarker development system based on over 5,000 patients’ clinic-/genomic information.
Big data & artificial intelligence based biomarker development service
Technology Big data platform
Massive clinical information accumulated through global collaborative research projects over 10 years
The Korea largest high-dimensional database (genomic & experimental) covers 8 types of cancers
Database management system for clinical and experimental(OMICS) data
Uniformized public database management system
Standard cancer transcriptomics gene expression atlas
Artificial Intelligence platform
CbsBioscience AI platform consists of CBS STATS, CBS MLBS, and CBS PINGS system.
It enables precision medicine a reality through the powerful and promising technology that integrates statistics, machine learning and mechanism investigation systems.
CBS STATS (multi-gene statistical analysis)
20 modules and 149 algorisms optimize multi-gene statistical analysis
CBS MLBS (biomarker validation)
Secure the success rate over 95% in clinical validation
via machine learning for cross validation technique
CBS PINGS (mechanism investigation)
Mechanism investigation analysis provides scientific evidence
for precision medicine and new drug development
Precision Medicine platform
A comprehensive cancer treatment solution provides prognostic, Predictive, and precision medicine system
is to identify likelihood of a clinical event, disease recurrence or
progression in patients who have the disease or medical condition of interest
is to identify individuals who are more likely than similar individuals
without the biomarker to experience a favorable or unfavorable effect
from exposure to a medical product or an environmental agent
Precision medicine system
is to investigate analysis provides scientific evidence for
precision medicine service and drug development
Prognostic & predictive test for liver cancer
A one-stop test that combines tests to predict the 5-year overall survival and the efficacy of treatment for liver cancer
It can significantly reduce the expense of diagnostic test and support the determination of treatment (surgery and/or therapeutic interventions)
Precision medicine service for liver cancer
It’s not only supporting the determination of conventional treatment, but also providing alternative therapeutic interventions for patients with no effective conventional treatment option.MORE
Clinical & experimental database establishment and biomarker developmentMORE